Assistant Professor of Clinical Pharmacy
University of California San Diego
Disclosure(s): CSL Sequiris: Advisor/Consultant, Honoraria; GSK: Advisor/Consultant, Honoraria; Novavax: Advisor/Consultant, Honoraria; Shionogi: Advisor/Consultant, Honoraria
Dr. Jacinda (JAM) Abdul-Mutakabbir is an Assistant Professor of Clinical Pharmacy at the University of California San Diego in the Skaggs School of Pharmacy and Pharmaceutical Sciences and the Division of the Black Diaspora and African American Studies. Her research is based on antimicrobial resistance and stewardship, where she identifies health disparities in various infectious diseases to inform tailored interventions for vulnerable communities. She has published more than 60 articles focused on identifying racial and social vulnerability differences in various infectious disease states, including Clostridium difficile infection, candidemia, and others. The United States Public Health Services has recognized her dedication to improving public health, as she was the 2017 recipient of the USPHS Outstanding Service Award, and she currently serves as an appointed member of the CVSH Health Equity National Advisory Board. In 2021, she received the Society of Infectious Disease Gita Patel Best Practice Award and the Wayne State University Warrior of Distinction of Alumni Award. Most recently, Dr. Abdul-Mutakabbir was named the 2023 recipient of the Infectious Diseases Society of America (IDSA) Clinical Practice Innovation Award, and in July 2024, she was appointed Editor of the Clinical Microbiology Reviews Journal. Dr. Abdul-Mutakabbir continues to be an active member of several professional organizations, including the American Society of Microbiology (ASM), the Infectious Diseases Society of America (IDSA), and the Society for Healthcare Epidemiology of America (SHEA).